FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225014864> ?p ?o ?g. }

• W4225014864 endingPage "142" @default.
• W4225014864 startingPage "134" @default.
• W4225014864 abstract "Abstract Purpose This article aims to review and assess the post-operative management and treatment outcomes of papillary thyroid microcarcinoma (PTMC) in risk-stratified patients. Methods We retrospectively analyzed the data of PTMC patients who underwent thyroid surgery with or without radioactive iodine treatment (RAI) in a single center between January 2011 and December 2017. Demographic and clinicopathologic data were collected. Risk stratification according to the 2015 American Thyroid Association guideline was applied. Results Three hundred forty PTMC patients were included. Post-operative RAI was performed in 216/340 (63.53%) patients. In the non-RAI scenario, there were 122 low-risk and two intermediate-risk patients. In total, 261 (76.77%), 57 (16.76%), and 22 (6.47%) patients were classified as low, intermediate, and high risk, respectively. With a median follow-up time of 36 months (interquartile range: 23, 52), we found unfavorable outcomes (evidenced by imaging or out-of-range serum tumor marker levels: high thyroglobulin [Tg] or rising Tg antibody [TgAb] levels) in 8/340 (2.35%) patients, all of which received RAI. PTMC patients with unfavorable outcomes were stratified as low risk (4/261 [1.53%]), intermediate risk (1/57 [1.75%]), or high risk (3/22 [13.64%]). One death occurred in a patient with initial distant metastasis in the high-risk group. Initial high-risk stratification and initial stimulated Tg (of at least 10 ng/mL) were demonstrated as independent predictors for PTMC unfavorable outcomes (persistent or recurrent disease). Five patients with unfavorable outcomes (four with persistent disease and one with recurrent disease) had abnormal Tg or TgAb values despite unremarkable imaging findings. Moreover, 79/124 (63.71%) patients in the non-RAI scenario were only followed up with neck ultrasound. Conclusions In general, at least 98% of low-risk and intermediate-risk PTMC patients showed favorable outcomes without persistent or recurrent disease, defined by either imaging or serum tumor markers. Nevertheless, aggressive disease could occur in few PTMC patients. Decisions on post-operative management and follow-up may be guided by initial high-risk stratification and initial stimulated Tg levels (≥10 ng/mL) as independent predictors for PTMC unfavorable outcomes. Monitoring using both imaging and serum tumor markers is crucial and should be implemented for patients with PTMC." @default.
• W4225014864 created "2022-04-29" @default.
• W4225014864 creator A5000602013 @default.
• W4225014864 creator A5007481005 @default.
• W4225014864 creator A5023516517 @default.
• W4225014864 creator A5025429139 @default.
• W4225014864 creator A5027358740 @default.
• W4225014864 creator A5035481622 @default.
• W4225014864 creator A5044058445 @default.
• W4225014864 creator A5054223829 @default.
• W4225014864 creator A5068407798 @default.
• W4225014864 creator A5080840726 @default.
• W4225014864 date "2022-04-27" @default.
• W4225014864 modified "2023-10-11" @default.
• W4225014864 title "Risk-stratified papillary thyroid microcarcinoma: post-operative management and treatment outcome in a single center" @default.
• W4225014864 cites W1965280723 @default.
• W4225014864 cites W1973648113 @default.
• W4225014864 cites W1975344814 @default.
• W4225014864 cites W1992679238 @default.
• W4225014864 cites W2001657996 @default.
• W4225014864 cites W2012247710 @default.
• W4225014864 cites W2030991783 @default.
• W4225014864 cites W2055366717 @default.
• W4225014864 cites W2056574751 @default.
• W4225014864 cites W2071165874 @default.
• W4225014864 cites W2078862938 @default.
• W4225014864 cites W2109909522 @default.
• W4225014864 cites W2129749079 @default.
• W4225014864 cites W2143439321 @default.
• W4225014864 cites W2143712324 @default.
• W4225014864 cites W2145150141 @default.
• W4225014864 cites W2149487804 @default.
• W4225014864 cites W2151789361 @default.
• W4225014864 cites W2171848461 @default.
• W4225014864 cites W2172111826 @default.
• W4225014864 cites W2176230063 @default.
• W4225014864 cites W2201969409 @default.
• W4225014864 cites W2276688783 @default.
• W4225014864 cites W2395912644 @default.
• W4225014864 cites W2401198183 @default.
• W4225014864 cites W2467616276 @default.
• W4225014864 cites W2514003649 @default.
• W4225014864 cites W2514582016 @default.
• W4225014864 cites W2531703927 @default.
• W4225014864 cites W2571663719 @default.
• W4225014864 cites W2581318616 @default.
• W4225014864 cites W2603577764 @default.
• W4225014864 cites W2652108520 @default.
• W4225014864 cites W2886823179 @default.
• W4225014864 cites W2945230648 @default.
• W4225014864 cites W2965370400 @default.
• W4225014864 cites W2975387808 @default.
• W4225014864 cites W2979950305 @default.
• W4225014864 cites W3017822239 @default.
• W4225014864 cites W3163694782 @default.
• W4225014864 cites W3191587567 @default.
• W4225014864 cites W3196897406 @default.
• W4225014864 cites W4220712737 @default.
• W4225014864 doi "https://doi.org/10.1007/s12020-022-03060-5" @default.
• W4225014864 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35476179" @default.
• W4225014864 hasPublicationYear "2022" @default.
• W4225014864 type Work @default.
• W4225014864 citedByCount "2" @default.
• W4225014864 countsByYear W42250148642023 @default.
• W4225014864 crossrefType "journal-article" @default.
• W4225014864 hasAuthorship W4225014864A5000602013 @default.
• W4225014864 hasAuthorship W4225014864A5007481005 @default.
• W4225014864 hasAuthorship W4225014864A5023516517 @default.
• W4225014864 hasAuthorship W4225014864A5025429139 @default.
• W4225014864 hasAuthorship W4225014864A5027358740 @default.
• W4225014864 hasAuthorship W4225014864A5035481622 @default.
• W4225014864 hasAuthorship W4225014864A5044058445 @default.
• W4225014864 hasAuthorship W4225014864A5054223829 @default.
• W4225014864 hasAuthorship W4225014864A5068407798 @default.
• W4225014864 hasAuthorship W4225014864A5080840726 @default.
• W4225014864 hasBestOaLocation W42250148641 @default.
• W4225014864 hasConcept C119060515 @default.
• W4225014864 hasConcept C126322002 @default.
• W4225014864 hasConcept C134018914 @default.
• W4225014864 hasConcept C141071460 @default.
• W4225014864 hasConcept C2780073493 @default.
• W4225014864 hasConcept C3020404979 @default.
• W4225014864 hasConcept C526584372 @default.
• W4225014864 hasConcept C555293320 @default.
• W4225014864 hasConcept C71924100 @default.
• W4225014864 hasConcept C90924648 @default.
• W4225014864 hasConceptScore W4225014864C119060515 @default.
• W4225014864 hasConceptScore W4225014864C126322002 @default.
• W4225014864 hasConceptScore W4225014864C134018914 @default.
• W4225014864 hasConceptScore W4225014864C141071460 @default.
• W4225014864 hasConceptScore W4225014864C2780073493 @default.
• W4225014864 hasConceptScore W4225014864C3020404979 @default.
• W4225014864 hasConceptScore W4225014864C526584372 @default.
• W4225014864 hasConceptScore W4225014864C555293320 @default.
• W4225014864 hasConceptScore W4225014864C71924100 @default.
• W4225014864 hasConceptScore W4225014864C90924648 @default.
• W4225014864 hasIssue "1" @default.
• W4225014864 hasLocation W42250148641 @default.

• next